Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantation
-
- Yoshihiro Inamoto
- National Cancer Center Hospital, Tokyo, Japan;
-
- Tomohiro Matsuda
- National Cancer Center Hospital, Tokyo, Japan;
-
- Ken Tabuchi
- Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;
-
- Saiko Kurosawa
- National Cancer Center Hospital, Tokyo, Japan;
-
- Hideki Nakasone
- Saitama Medical Center, Jichi Medical University, Saitama, Japan;
-
- Hisakazu Nishimori
- Okayama University Hospital, Okayama, Japan;
-
- Satoshi Yamasaki
- National Hospital Organization Kyushu Medical Center, Fukuoka, Japan;
-
- Noriko Doki
- Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan;
-
- Koji Iwato
- Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital, Hiroshima, Japan;
-
- Takehiko Mori
- Keio University School of Medicine, Tokyo, Japan;
-
- Satoshi Takahashi
- The Institute of Medical Science, The University of Tokyo, Tokyo, Japan;
-
- Hiromasa Yabe
- Tokai University Hospital, Isehara, Japan;
-
- Akio Kohno
- JA Aichi Konan Kosei Hospital, Konan, Japan;
-
- Hirohisa Nakamae
- Osaka City University, Osaka, Japan;
-
- Toru Sakura
- Saiseikai Maebashi Hospital, Gunma, Japan;
-
- Hisako Hashimoto
- Kobe City Medical Center General Hospital, Kobe, Japan;
-
- Junichi Sugita
- Hokkaido University Hospital, Sapporo, Japan;
-
- Hiroatsu Ago
- Shimane Prefectural Central Hospital, Izumo, Japan;
-
- Takahiro Fukuda
- National Cancer Center Hospital, Tokyo, Japan;
-
- Tatsuo Ichinohe
- Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;
-
- Yoshiko Atsuta
- Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan; and
-
- Takuya Yamashita
- St. Luke’s International Hospital, Tokyo, Japan
Description
<jats:title>Key Points</jats:title> <jats:p>Subsequent solid cancers after HCT occurred at younger ages than primary cancers and accounted for most common causes of deaths. Subsequent solid cancers after HCT showed similar or worse survival compared with primary cancers in the general population.</jats:p>
Journal
-
- Blood Advances
-
Blood Advances 2 (15), 1901-1913, 2018-08-07
American Society of Hematology
- Tweet
Details 詳細情報について
-
- CRID
- 1362262946008796416
-
- ISSN
- 24739537
- 24739529
-
- Data Source
-
- Crossref
